The New Zealand Association of Optometrists (NZAO) is hosting its very first peer-support conference for hospital optometrists on 2 September at the Rydges Wellington Airport hotel.
In the six years since publication of the evidence-based TFOS DEWS II reports¹, awareness and acknowledgement of dry eye disease (DED) as a growing global concern has continued to intensify. These reports reached consensus with respect to the diagnosis, classification, diagnosis and management of DE
In a world first, ophthalmologists at Flinders University, South Australia, will trial an early-intervention laser treatment designed to treat people at high risk of losing sight from glaucoma.
The Ocular Surface Laboratory’s team of clinician scientists at the University of Auckland is dedicated to improving patient outcomes through developing a better understanding of ocular surface and
A genetic saliva test indicating glaucoma risk is expected to be available to eyecare professionals by the end of this year, with its Australian developers saying it could also warn of aggressive
Ocuphire Pharma announced its Zeta-1 phase 2 trial showed oral diabetic retinopathy (DR) treatment APX3330 reduced patients’ progression on the diabetic retinopathy severity scale (DRSS) after 24
Bespoke protective ‘sunglasses’ designed for puffins helped researchers demonstrate the birds’ bills fluoresce in ultraviolet (UV) light.
The World Health Organization (WHO) reported the number of people at risk from trachoma, the world's leading infectious cause of blindness, fell from 125 million in 2022 to 115.7m in 2023. In 2022,
Glaukos announced it has entered into a collaboration and marketing agreement with Radius XR, the developers of a diagnostic device to conduct patient-guided vision exams. A Glaukos statement
Bausch + Lomb (B+L) has acquired Johnson & Johnson Vision’s Blink product line of over-the-counter (OTC) eye and contact lens drops. “There’s a growing need for relieving the symptoms of dry eyes and
The author of four editions of Pickwell’s Binocular Vision Anomalies and more than 260 publications, clinical optometrist Professor Bruce Evans recently received a lifetime achievement award from the
Australia’s Professor Graham Barrett has been inducted into The Ophthalmologist’s inaugural Hall of Fame, an accolade bestowed on individuals deemed to have had an impact on the profession which will
